← All stocks

GALECTIN THERAPEUTICS INC

GALT Net selling

CIK 0001133416 #3361 in the set updated 17 Sep 2026

Bought (12 mo)

$25.55K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$6.07M

$595.80K on a plan · $3.96M straight out of an exercise

Sold at will

$1.51M

6 of 67 sales

Net

−$6.04M

−$1.49M against sales at will

By person

10 insiders · 73 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Shlevin Harold H.

Director

—

$1.56M (14) scheduled

−$1.56M

26,123

$133.89K

−7.1%

10X Fund, L.P. entity

10% owner

—

$1.51M (6)

−$1.51M

5,614,457

$28.78M

−5.0%

Jamil Khurram

Chief Medical Officer

—

$1.44M (17) scheduled

−$1.44M

$0.00

—

CALLICUTT JACK W

Chief Financial Officer

—

$944.40K (20) scheduled

−$944.40K

7,614

$39.02K

0.0%

LEWIS JOEL

President and CEO

—

$620.54K (10) scheduled

−$620.54K

832,592

$4.27M

−6.3%

FREEMAN KEVIN D

Director

$19.51K (1)

—

+$19.51K

135,269

$693.28K

+30.7%

ELDRED KARY

Director

$6.03K (3)

—

+$6.03K

65,682

$336.63K

+34.0%

Uihlein Richard E

Director

—

55,046,519

$282.12M

+166.9%

CZIRR JAMES C

10% owner

—

1,045,541

$5.36M

+41.0%

Zordani Richard A. Jr.

Director

—

42,083

$215.68K

+31.2%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Jamil Khurram

6 Jan 2026

Chief Medical Officer

Sold on a plan

21,446

$3.65

$78.20K

CALLICUTT JACK W

6 Jan 2026

Chief Financial Officer

Sold on a plan

20,354

$3.67

$74.70K

LEWIS JOEL

6 Jan 2026

President and CEO

Sold on a plan

37,698

$3.58

$134.85K

Jamil Khurram

5 Jan 2026

Chief Medical Officer

Sold on a plan

25,499

$3.90

$99.41K

CALLICUTT JACK W

5 Jan 2026

Chief Financial Officer

Sold on a plan

25,732

$3.90

$100.30K

LEWIS JOEL

5 Jan 2026

President and CEO

Sold on a plan

27,731

$3.91

$108.34K

Show all 73 transactions →

What was left out

Form 4 filings counted 46

Amendments (4/A) skipped 4

Filings about a different issuer 0

Unreadable filings 0

Joint filings 4

Sales on a Rule 10b5-1 plan 6

Sales straight out of an exercise 55

Sales at will 6

Transactions with no price 0

Shares from compensation/vesting 35,230,404

History held since 24 Oct 2016